Bleakley Financial Group’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-48,296
| Closed | -$268K | – | 940 |
|
|
2024
Q4 | $268K | Buy |
48,296
+34,984
| +263% | +$194K | 0.01% | 840 |
|
|
2024
Q3 | $111K | Buy |
13,312
+2,751
| +26% | +$22.9K | ﹤0.01% | 962 |
|
|
2024
Q2 | $71.9K | Buy |
+10,561
| New | +$71.9K | ﹤0.01% | 963 |
|
|
2024
Q1 | – | Sell |
-10,452
| Closed | -$67.8K | – | 1025 |
|
|
2023
Q4 | $67.8K | Buy |
+10,452
| New | +$67.8K | ﹤0.01% | 913 |
|